| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |